×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| PARNAX LAB LTD. | 404.06 | 12.12 | 402.16 | 1.06 | 115.0 | 10.6 |
| AAREY DRUGS & PHARMACEUTICALS | 1,344.68 | 7.18 | 1,337.89 | 0.26 | 115 | 20.2 |
| FORTIS MALAR HOSPITALS LIMITED | 5.60 | 0.08 | 0.00 | 0.00 | 112 | 145.0 |
Parnax Lab Limited, with Security Code 506128, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.1 | 0.7 | 1.1 | 2.4 | 1.1 | 1.8 | 2.7 | 1.7 | 3.6 | 1.5 |
| Expenses | 2.5 | 0.8 | 1.0 | 1.5 | 1.1 | 1.1 | 1.5 | 1.5 | 2.4 | 1.3 |
| Operating Profit | 0.6 | -0.1 | 0.1 | 0.9 | 0.0 | 0.7 | 1.2 | 0.2 | 1.3 | 0.2 |
| OPM % | 18.98% | -7.79% | 10.5% | 37.66% | 1.86% | 38.21% | 44.47% | 9.31% | 34.23% | 12.96% |
| Other Income | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| Interest | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.6 | -0.1 | 0.2 | 1.0 | 0.1 | 0.8 | 1.3 | 0.2 | 1.4 | 0.4 |
| Tax % | 25.9% | -55.9% | 37.7% | 26.7% | 25.8% | 24.4% | 25.6% | 28.1% | 25.2% | 25.2% |
| Net Profit | 0.4 | 0.0 | 0.1 | 0.7 | 0.1 | 0.6 | 1.0 | 0.2 | 1.1 | 0.3 |
| EPS in Rs | 0.42 | -0.04 | 0.1 | 0.66 | 0.06 | 0.52 | 0.86 | 0.15 | 0.91 | 0.24 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.1 | 46.8 | 40.9 | 48.7 | 42.6 | 51.0 | 46.4 | 50.1 | 48.4 | 40.2 |
| Expenses | 37.6 | 39.5 | 36.2 | 42.3 | 37.3 | 45.0 | 40.6 | 41.5 | 41.1 | 35.9 |
| Operating Profit | 5.6 | 7.4 | 4.7 | 6.5 | 5.3 | 6.0 | 5.8 | 8.6 | 7.2 | 4.3 |
| OPM % | 12.9% | 15.7% | 11.6% | 13.3% | 12.4% | 11.7% | 12.5% | 17.2% | 15% | 10.6% |
| Other Income | 0.3 | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 1.0 | 0.2 |
| Interest | 1.2 | 1.3 | 1.2 | 1.2 | 1.4 | 1.4 | 1.4 | 1.5 | 1.4 | 1.2 |
| Depreciation | 1.5 | 1.7 | 1.6 | 1.6 | 1.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.8 |
| Profit before tax | 3.1 | 4.4 | 2.2 | 4.0 | 2.3 | 2.9 | 2.8 | 5.4 | 4.9 | 1.5 |
| Tax % | 32.4% | 28.6% | 44.1% | 16.4% | 20% | 25.9% | 19.5% | 26.2% | 29.9% | 16.2% |
| Net Profit | 2.1 | 3.2 | 1.4 | 3.3 | 1.9 | 2.2 | 2.2 | 4.0 | 3.4 | 1.2 |
| EPS in Rs | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 1 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 3% |
| 3 Years: | 46% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 33% |
| 3 Years: | 53% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 48% |
| 3 Years: | -1% |
| 1 Year: | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 28% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 24% |
| 3 Years: | 203% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 48% |
| 3 Years: | -1% |
| 1 Year: | 14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|